Article | March 28, 2017

The Upswing Of Sterile Injectables

Source: Piramal Pharma Solutions
The Upswing of Sterile Injectables

The $330 bn global sterile market is expected to reach $525 bn by 2020, growing at a CAGR of 11% -with North America contributing 48% while APAC is expected to record highest CAGR of 13%.

By 2026, contract manufacturing of sterile injectables will account for 25.7% of contract final dosage form (FDF) manufacturing revenues, up from 22.3% in 2014. This reflects the general trend in drug development towards injectable therapies.